Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05252364
Title A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hinova Pharmaceuticals Aus Pty Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Border Medical Oncology Albury New South Wales 2640 Australia Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
Macquarie University Macquarie Park New South Wales 2113 Australia Details
Peter McCallum Cancer Center Melbourne Victoria 3000 Australia Details
Alfred Hospital Melbourne Victoria 3181 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field